NTRC delivers its drug discovery capabilities as fee-for-service for development projects of druggable protein target classes. NTRC is also the European representative for Carna Biosciences Inc. for kinase profiling and reverse phase phospho-protein array technology (RPPA). For the expansion of the roll-out of these services NTRC has recently appointed Dr. Suzanne van Gerwen as Sales Manager Services.
Dr. Suzanne van Gerwen has a broad experience in various areas of the Life Science industry. In the past 14 years she has been active in research, R&D management, operational management, business development and sales in the (bio)pharmaceutical, biotechnological and food industry, mainly in a business to business context. Her contact details are: [email protected]
More information on the service portfolio of NTRC can be found on www.ntrc.nl